Prof.dr. Peter-Bram ’t Hoen obtained his Master degrees in Biochemistry and Pharmacochemistry cum laude from the Vrije Universiteit Amsterdam. In 2002, he received his PhD degree from Leiden University. His PhD thesis was entitled “Modulating the activity of biotransformation enzymes. He established a research line at Leiden University Medical Center on developing biomarkers and antisense therapies for Duchenne Muscular Dystrophy, exploiting high-dimensional molecular data. He started in February 2018 as full professor of Bioinformatics at Radboud University Medical Center Nijmegen. In this position, he is dedicated to the advancement of personalized medicine approaches for rare diseases by integrative use of -omics and clinical data. ’t Hoen is coordinator of the European SIMPATHIC project aiming for acceleration of drug repurposing for rare neurological, neurometabolic and neuromuscular disorders. He is leading the Radboudumc program on neuromuscular disorders and has myotonic dystrophy as disease focus. ‘t Hoen is directing the data analysis, integration and stewardship pillar within the Netherlands X-omics initiative. He is actively contributing to other national infrastructures such as HealthRI, and international infrastructures such as European Joint Programme on Rare Diseases, EURO-NMD registry, EATRIS and ELIXIR.
